梅斯医学荣登2020未来医疗100强数字营销类Top10

2021-03-05 网络 网络

梅斯医学荣登2020未来医疗100强·价值领域榜数字营销类Top10

2020年,数字化医药营销市场在政策和疫情的催化下迎来了转型升级的新机遇,数字化营销成为医药市场越来越重要的营销手段。

梅斯医学凭借多年来在医疗健康和医药行业的深耕,以专业医学学术能力为基础,坚持学术与数字化双轮驱动,助力营销创新探索,荣登2020未来医疗100强·价值领域榜数字营销类Top10

数字营销类Top10榜单

未来医疗100强榜单是由动脉网推出的国内首个针对非上市企业的创新医疗领域榜单,以擅长发掘驱动健康医疗产业经济增长的具有潜力的新兴医疗科技公司而著称,被誉为医疗行业“风向标”。

榜单的评定不以单一估值为评选标准,采用多维价值评估模型,从企业的技术潜力、商业潜力、综合竞争力三个方向切入,综合评估企业在技术创新、技术壁垒、转化周期、终端潜力、商业模式创新、科研能力、供应链能力、商业化能力、公共事务处理能力等多维度的表现与潜力,由专家评审团进行综合评估与打分。经过为期2个月的项目征集、项目评选,评选出2020年度未来医疗100强·价值领域榜,梅斯医学从上千家新型科技公司中脱颖而出,跻身数字营销类Top10榜单。

梅斯医学(MedSci)是面向医生的综合互联网平台,应用大数据和人工智能技术链接医生、患者、药械企业等,提供精准数字化医学传播解决方案,优化医疗生态,改善医疗质量,共创美好健康生活。

自2008年成立以来,梅斯医学始终秉持着改善医疗质量的企业使命,以医学为根基,数字化为工具,通过互联网和大数据计算等技术为临床科研和临床实践提供智慧、精准的决策支持,用数字化技术让医学更有效率,更好的服务社会。

凭借雄厚的医学学术能力和专业的数字化平台,梅斯医学主要关注数字化医学传播和数字化临床研究领域,在数字化医学传播方面,为制药企业提供数字化的专业医学内容和精准、整合的传播方案,将创新药的医学证据快速触达目标医生,加强用药指导,让更多的医生第一时间了解创新药物的特性与价值,让医生更放心、合理地在临床上应用这些药物,让患者早用好药、规范用药,实现患者、医生、企业共同受益;在数字化临床研究方面,提供临床研究整体解决方案,通过数字化技术降低成本,提升质量,为创新药物产生医学证据,发掘产品的价值。

梅斯医学董事长张发宝博士多次强调,梅斯医学不是一家服务于制药企业的公司,而是与制药企业形成合作伙伴,连接药企,服务医生,造福患者。未来,梅斯医学将继续深耕医疗健康行业,以数字化技术和医学学术能力赋能整个医疗行业,为医疗健康和生物医药行业的发展贡献自己的一份力量。

目前,梅斯医学已为国内外多家知名药企和器械公司提供包含数字化学术营销、真实世界研究、医学事务等多种解决方案,合作伙伴包括西安杨森、辉瑞、诺华、罗氏、阿斯利康、赛诺菲、恒瑞、正大天晴、先声制药、石药集团等国内外领先的企业。

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1649870, encodeId=796d16498e030, content=<a href='/topic/show?id=f1e41e642cd' target=_blank style='color:#2F92EE;'>#TOP10#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17642, encryptionId=f1e41e642cd, topicName=TOP10)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb7b23929551, createdName=respect, createdTime=Tue Jun 22 21:04:02 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2054039, encodeId=13b620540391a, content=<a href='/topic/show?id=28b16086327' target=_blank style='color:#2F92EE;'>#未来医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60863, encryptionId=28b16086327, topicName=未来医疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca282500032, createdName=1249857fm32暂无昵称, createdTime=Thu Nov 04 19:04:02 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950038, encodeId=90f5950038dc, content=好👍🏻, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201117/a59b28b63198490ea85b1e5b3d13c2bf/1b1e0d03ca22467d8120443ebbc24c04.jpg, createdBy=35d22207591, createdName=zhangxiang, createdTime=Mon Mar 22 08:51:22 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1277173, encodeId=52e612e7173c8, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sun Mar 07 05:04:02 CST 2021, time=2021-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945820, encodeId=c5c794582085, content=恭喜, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e502075746, createdName=营养医师, createdTime=Fri Mar 05 19:51:13 CST 2021, time=2021-03-05, status=1, ipAttribution=)]
    2021-06-22 respect
  2. [GetPortalCommentsPageByObjectIdResponse(id=1649870, encodeId=796d16498e030, content=<a href='/topic/show?id=f1e41e642cd' target=_blank style='color:#2F92EE;'>#TOP10#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17642, encryptionId=f1e41e642cd, topicName=TOP10)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb7b23929551, createdName=respect, createdTime=Tue Jun 22 21:04:02 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2054039, encodeId=13b620540391a, content=<a href='/topic/show?id=28b16086327' target=_blank style='color:#2F92EE;'>#未来医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60863, encryptionId=28b16086327, topicName=未来医疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca282500032, createdName=1249857fm32暂无昵称, createdTime=Thu Nov 04 19:04:02 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950038, encodeId=90f5950038dc, content=好👍🏻, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201117/a59b28b63198490ea85b1e5b3d13c2bf/1b1e0d03ca22467d8120443ebbc24c04.jpg, createdBy=35d22207591, createdName=zhangxiang, createdTime=Mon Mar 22 08:51:22 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1277173, encodeId=52e612e7173c8, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sun Mar 07 05:04:02 CST 2021, time=2021-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945820, encodeId=c5c794582085, content=恭喜, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e502075746, createdName=营养医师, createdTime=Fri Mar 05 19:51:13 CST 2021, time=2021-03-05, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1649870, encodeId=796d16498e030, content=<a href='/topic/show?id=f1e41e642cd' target=_blank style='color:#2F92EE;'>#TOP10#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17642, encryptionId=f1e41e642cd, topicName=TOP10)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb7b23929551, createdName=respect, createdTime=Tue Jun 22 21:04:02 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2054039, encodeId=13b620540391a, content=<a href='/topic/show?id=28b16086327' target=_blank style='color:#2F92EE;'>#未来医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60863, encryptionId=28b16086327, topicName=未来医疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca282500032, createdName=1249857fm32暂无昵称, createdTime=Thu Nov 04 19:04:02 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950038, encodeId=90f5950038dc, content=好👍🏻, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201117/a59b28b63198490ea85b1e5b3d13c2bf/1b1e0d03ca22467d8120443ebbc24c04.jpg, createdBy=35d22207591, createdName=zhangxiang, createdTime=Mon Mar 22 08:51:22 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1277173, encodeId=52e612e7173c8, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sun Mar 07 05:04:02 CST 2021, time=2021-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945820, encodeId=c5c794582085, content=恭喜, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e502075746, createdName=营养医师, createdTime=Fri Mar 05 19:51:13 CST 2021, time=2021-03-05, status=1, ipAttribution=)]
    2021-03-22 zhangxiang

    好👍🏻

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1649870, encodeId=796d16498e030, content=<a href='/topic/show?id=f1e41e642cd' target=_blank style='color:#2F92EE;'>#TOP10#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17642, encryptionId=f1e41e642cd, topicName=TOP10)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb7b23929551, createdName=respect, createdTime=Tue Jun 22 21:04:02 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2054039, encodeId=13b620540391a, content=<a href='/topic/show?id=28b16086327' target=_blank style='color:#2F92EE;'>#未来医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60863, encryptionId=28b16086327, topicName=未来医疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca282500032, createdName=1249857fm32暂无昵称, createdTime=Thu Nov 04 19:04:02 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950038, encodeId=90f5950038dc, content=好👍🏻, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201117/a59b28b63198490ea85b1e5b3d13c2bf/1b1e0d03ca22467d8120443ebbc24c04.jpg, createdBy=35d22207591, createdName=zhangxiang, createdTime=Mon Mar 22 08:51:22 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1277173, encodeId=52e612e7173c8, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sun Mar 07 05:04:02 CST 2021, time=2021-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945820, encodeId=c5c794582085, content=恭喜, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e502075746, createdName=营养医师, createdTime=Fri Mar 05 19:51:13 CST 2021, time=2021-03-05, status=1, ipAttribution=)]
    2021-03-07 一闲
  5. [GetPortalCommentsPageByObjectIdResponse(id=1649870, encodeId=796d16498e030, content=<a href='/topic/show?id=f1e41e642cd' target=_blank style='color:#2F92EE;'>#TOP10#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17642, encryptionId=f1e41e642cd, topicName=TOP10)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb7b23929551, createdName=respect, createdTime=Tue Jun 22 21:04:02 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2054039, encodeId=13b620540391a, content=<a href='/topic/show?id=28b16086327' target=_blank style='color:#2F92EE;'>#未来医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60863, encryptionId=28b16086327, topicName=未来医疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca282500032, createdName=1249857fm32暂无昵称, createdTime=Thu Nov 04 19:04:02 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950038, encodeId=90f5950038dc, content=好👍🏻, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201117/a59b28b63198490ea85b1e5b3d13c2bf/1b1e0d03ca22467d8120443ebbc24c04.jpg, createdBy=35d22207591, createdName=zhangxiang, createdTime=Mon Mar 22 08:51:22 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1277173, encodeId=52e612e7173c8, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sun Mar 07 05:04:02 CST 2021, time=2021-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945820, encodeId=c5c794582085, content=恭喜, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e502075746, createdName=营养医师, createdTime=Fri Mar 05 19:51:13 CST 2021, time=2021-03-05, status=1, ipAttribution=)]
    2021-03-05 营养医师

    恭喜

    0